Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Ferré JM, Windecker S, Dudek D, Baumbach A. Chieffo A, et al. Among authors: windecker s. EuroIntervention. 2020 Jun 25;16(3):233-246. doi: 10.4244/EIJY20M05_01. EuroIntervention. 2020. PMID: 32404302 Free article.
Early exercise after coronary stenting is safe.
Roffi M, Wenaweser P, Windecker S, Mehta H, Eberli FR, Seiler C, Fleisch M, Garachemani A, Pedrazzini GB, Hess OM, Meier B. Roffi M, et al. Among authors: windecker s. J Am Coll Cardiol. 2003 Nov 5;42(9):1569-73. doi: 10.1016/j.jacc.2003.06.006. J Am Coll Cardiol. 2003. PMID: 14607440 Free article. Clinical Trial.
Prognostic value of early exercise testing after coronary stent implantation.
Wenaweser P, Surmely JF, Windecker S, Roffi M, Togni M, Billinger M, Cook S, Vogel R, Seiler C, Hess OM, Meier B. Wenaweser P, et al. Among authors: windecker s. Am J Cardiol. 2008 Mar 15;101(6):807-11. doi: 10.1016/j.amjcard.2007.10.046. Epub 2008 Jan 14. Am J Cardiol. 2008. PMID: 18328845 Clinical Trial.
Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Marra S, Moretti C, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW. Meliga E, et al. Among authors: windecker s. Int J Cardiol. 2009 Sep 11;137(1):16-21. doi: 10.1016/j.ijcard.2008.06.006. Epub 2008 Aug 6. Int J Cardiol. 2009. PMID: 18687481
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT).
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Cruz-Gonzalez I, Marra S, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW. Meliga E, et al. Among authors: windecker s. EuroIntervention. 2008 May;4(1):77-83. doi: 10.4244/eijv4i1a14. EuroIntervention. 2008. PMID: 19112783
Scientific societies and clinical trials.
Di Mario C, James S, Ludman P, Windecker S, Sabate M. Di Mario C, et al. Among authors: windecker s. EuroIntervention. 2010 Jun;6(2):185-8. EuroIntervention. 2010. PMID: 20562066 No abstract available.
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.
Serruys PW, Garg S, Abizaid A, Ormiston J, Windecker S, Verheye S, Dubois C, Stewart J, Hauptmann KE, Schofer J, Stangl K, Witzenbichler B, Wiemer M, Barbato E, de Vries T, den Drijver AM, Otake H, Meredith L, Toyloy S, Fitzgerald P. Serruys PW, et al. Among authors: windecker s. EuroIntervention. 2010 Jun;6(2):195-205. EuroIntervention. 2010. PMID: 20562069 Clinical Trial.
1,482 results